HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells Ex Vivo  by Antonchuk, Jennifer et al.
Cell, Vol. 109, 39–45, April 5, 2002, Copyright 2002 by Cell Press
HOXB4-Induced Expansion of
Adult Hematopoietic Stem Cells Ex Vivo
initiated with highly purified HSC populations and high
concentrations of early-acting cytokines (Conneally et
al., 1997; Miller and Eaves, 1997). However, optimization
Jennifer Antonchuk,1 Guy Sauvageau,2,4
and R. Keith Humphries1,3,4
1Terry Fox Laboratory
British Columbia Cancer Agency of cytokine combinations does not seem to be sufficient
to induce clinically significant HSC expansions, as it601 West 10th Avenue
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Department of Medicine ways, whose activation has caused some HSC expan-
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led to immortalization of blast-like cells that retainedCanada
lympho-myeloid differentiation and long-term repopu-
lating ability (Varnum-Finney et al., 2000). Addition of
soluble Sonic Hedgehog protein to liquid cultures ofSummary
human bone marrow cells led to at least 3-fold expan-
sion of SCID-repopulating cells via modulation of BMP4Hox transcription factors have emerged as important
regulators of primitive hematopoietic cell proliferation levels (Bhardwaj et al., 2001). However, none of these
ex vivo systems have achieved HSC expansions compa-and differentiation. In particular, HOXB4 appears to
be a strong positive regulator of hematopoietic stem rable to the up to 100-fold HSC regeneration demon-
strated in vivo following bone marrow transplantationcell (HSC) self-renewal. Here we demonstrate the po-
tency of HOXB4 to enable high-level ex vivo HSC (Pawliuk et al., 1996).
We have been interested in the Hox family of transcrip-expansion. Cultures of nontransduced or GFP-trans-
duced murine bone marrow cells experienced large tion factors, whose deregulated expression have effects
on hematopoietic proliferation and differentiation rang-HSC losses over 10–14 days. In sharp contrast, cul-
tures of HOXB4-transduced cells achieved rapid, ex- ing from blocked lymphoid development (Sauvageau et
al., 1997) to acute myeloid leukemia (Borrow et al., 1996;tensive, and highly polyclonal HSC expansions, re-
sulting in over 1000-fold higher levels relative to Buske and Humphries, 2000; Lawrence et al., 1999;
Thorsteinsdottir et al., 1997). In particular, retroviral ov-controls and a 40-fold net HSC increase. Importantly,
these HSCs retained full lympho-myeloid repopulating erexpression of HOXB4 significantly enhanced in vivo
HSC regeneration, with 1000-fold net increases ofpotential and enhanced in vivo regenerative potential,
demonstrating the feasibility of achieving significant transduced HSC in both primary and secondary recipi-
ents (Antonchuk et al., 2001; Sauvageau et al., 1995;ex vivo expansion of HSCs without functional im-
pairment. Thorsteinsdottir et al., 1999). HOXB4 overexpression
specifically enhanced the rate of HSC expansion without
impairing normal differentiation or causing the cells toIntroduction
become transformed.
Using long-term in vivo repopulation of mice and prin-The relative inability to expand hemopoietic stem cells
(HSCs) ex vivo imposes major limitations on the current ciples of limiting dilution to quantitatively determine HSC
expansion, we now demonstrate that HOXB4 has theuse of HSC transplantation. This is especially true in
cases where the number of available stem cells is lim- unique capacity to induce HSC expansion ex vivo to
values measured at more than 3 logs over controls initing (e.g., cord blood-derived stem cells for transplanta-
tion into adults). While studies have shown that self- short-term liquid cultures. The expanded stem cell pop-
ulation remained competitive and multipotent (B, T, andrenewal is clearly possible in vitro (Ema et al., 2000;
Fraser et al., 1990; Glimm and Eaves, 1999), most culture myeloid) in primary and in secondary recipients.
conditions nonetheless result in net HSC losses, indicat-
ing that differentiation is favored over expansion. Sev- Results
eral studies have documented maintenance and moder-
ate (3-fold) expansions of HSCs in serum-free cultures Ex Vivo Expansion of HOXB4-Overexpressing HSC
Ex vivo expansion of HSCs was determined in cultures
of nontransduced, control-transduced, and HOXB4-4 Correspondence: khumphri@bccancer.bc.ca (R.K.H.), sauvagg@
ircm.qc.ca (G.S.) transduced cells using a modification of the CRU assay
Cell
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Figure 1. Ex Vivo Expansion of Mature Cells
and Progenitors
(A) Growth of total nucleated cells over 14
days in nontransduced (), GFP (), and
HOXB4 () cultures.
(B) Proportions of transduced (GFP) cells
in GFP and HOXB4 cultures. The dramatic
increase in GFP cells in the HOXB4 culture
reflects a cell-autonomous growth advantage
conferred by HOXB4.
(C) Growth of clonogenic progenitors (CFC)
in nontransduced (), GFP (), and HOXB4O-
HoH () cultures over 14 days.
(D) GFP and GFP CFC after 14 days of
culture. While the proportion of GFP CFCs
reflects the input transduction efficiency in
the GFP culture, the predominance of GFP
CFCs in the HOXB4 culture reflects a HOXB4-
mediated growth advantage.
as previously described (Antonchuk et al., 2001). Mouse complete concordance between the detection of donor-
derived (Ly5.1) and HOXB4-transduced (GFP) cells inbone marrow cells harvested 4 days after intravenous
injection of 5-fluorouracil (5-FU) were grown for 2 days repopulated mice, even at limit dilution.
These results were reproduced in a second experi-in the presence of serum and hematopoietic cytokines.
The nontransduced group then continued to be cultured ment and again indicated a similar difference in HSC
values between the GFP and the HOXB4 cultures (Figurein the same media, while the other two groups (hereafter
referred to as the GFP and HOXB4 cultures) were trans- 2B). Two additional experiments (i.e., Expts 3 and 4,
Figure 2C) evaluating HSC content at day 6 of cultureduced with retroviruses carrying either GFP alone or
HOXB4 and GFP for an additional 2 days, resulting in (i.e., 4 days after initial exposure to retrovirus) showed
the reproducibility of these findings (Figure 2C).infection efficiencies of 44% and 33%, respectively. The
three groups were then cultured for an additional 10
days, without selection for GFP-expressing cells. HOXB4-Transduced HSCs Are Competitive
and PluripotentGrowth of total cells, GFP cells, clonogenic progeni-
tors, and HSCs were monitored at intervals of 2–4 days. To confirm that the expanded HSCs retained full multilin-
eage repopulation ability, FACS analysis was performedHOXB4 overexpression gave a moderate 2- to 3-fold
growth advantage to total cells and progenitors during on bone marrow, spleen, and thymus samples of mice
transplanted 16 weeks previously, with cells harvestedthe 14-day culture (Figures 1A and 1C). This was due to
a selective expansion of transduced cells, demonstrated at day 14 from the cultures described above. The pres-
ence of transduced (GFP) cells in marrow myeloid andby the rapid predominance of GFP cells and progeni-
tors which occurred only in the HOXB4 culture (Figures erythroid cells, splenic B cells, and thymic T cells from
representative recipients indicated that the expanded1B and 1D).
HSC numbers in these cultures were measured every cells from either the GFP or HOXB4 cultures were not
compromised in their capacity to differentiate along my-2–4 days by in vivo limiting dilution analysis. Although
the HSC contents of the three cultures were initially eloid and lymphoid lineages (Figure 3A). Clonal analyses
based on proviral integration sites were performed usingequivalent at approximately 7000 CRU, they rapidly in-
creased in the culture containing HOXB4-transduced purified subpopulations of bone marrow myeloid cells
(Gr-1 or Mac-1), splenic B cells (B220), and thymiccells, with 8-fold expansion by day 6 and a further 5-fold
expansion by day 14, when the experiment was termi- T cells (CD4 or CD8) (Figure 3B). The identical proviral
integration sites in myeloid, B, and T lineages of a repre-nated. As a result, there was a net 41-fold HSC expan-
sion over 14 days in the HOXB4 culture (Figure 2A). This sentative mouse transplanted with cells from the HOXB4
culture demonstrated the pluripotent nature of an ex-strikingly contrasted with control nontransduced and
GFP cultures, in which a constant decrease in HSC con- panded HSC clone.
The proliferative potential of the expanded HOXB4-tent resulted in 29- to 58-fold HSC reductions, respec-
tively, by day 14. Combining the net HSC loss in the transduced HSCs was further evaluated by measuring
their ability to regenerate the HSC compartment in vivo.GFP culture and the net HSC gain in the HOXB4 culture
resulted in an overall difference of over 1000-fold HSC To that end, we performed CRU assays on bone marrow
cells from mice transplanted 4 months previously withcontent between these two cultures. This expansion
was restricted to HOXB4-transduced cells, as there was cells from the 14-day GFP or HOXB4 cultures. While the
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the number of different HSC clones that were expanded
during the ex vivo cultures described in the first section.
For this, we assessed the number of different trans-
duced clones that contributed to long-term repopulation
when multiple HSCs harvested at day 10 or day 14 from
GFP or HOXB4 cultures were transplanted.
Cultures containing GFP-transduced cells contained
approximately 300 and 400 transduced HSCs at day 10
in experiments 1 and 2, respectively. Yet recipients of
high doses of GFP-transduced cells had clonal to oligo-
clonal reconstitution (Figure 5, top) at 4 months post-
transplant, suggesting that while a few selected clones
expanded, the vast majority of the HSC population was
lost in these cultures. In contrast, recipients of similar
numbers of HOXB4-transduced HSCs (but much lower
cell doses, see Figure legend) showed a highly poly-
clonal reconstitution (Figure 5, bottom), indicating that
HOXB4-tranduced HSCs survived and expanded during
the 14 day culture (see Figure 6). Thus, the enhanced
HSC expansion in HOXB4 bone marrow cultures can be
explained at least in part by an increased retention of
stem cell clones.
Discussion
Based on previous studies showing the potential of in-
trinsic factors to control HSC self-renewal decisions and
our previous results showing marked enhancement of
HSC regeneration mediated by HOXB4 in vivo, we hy-
Figure 2. Ex Vivo Expansion of HSCs pothesized that HOXB4 overexpression might enable
(A) Change in HSC number over 14 days in nontransduced (grey enhanced HSC recovery after ex vivo culture. A simple
diamond), GFP-transduced (black square), or HOXB4-transduced
bulk bone marrow cell culture containing serum, IL-3,(open triangle) BM cultures. Shown are the absolute number of CRU
IL-6, and SF was used, and in this system we docu-(mean  95% confidence intervals) in the culture. While the control
mented a HOXB4-mediated net HSC expansion ofcultures experienced significant HSC decreases, the HOXB4 cul-
tures achieved a 40-fold net HSC increase. Asterisks indicate a greater than 40-fold in 14 days. Moreover, the expansion
significant difference (p  0.0001) between HOXB4 and GFP cul- occurred quite rapidly, with significant HSC growth re-
tures. corded in just a few days. These cultures were initiated
(B) A second, 10-day experiment confirmed the net changes in HSC
with nonselected populations containing approximatelynumber. Values are shown relative to starting numbers (set to 1).
30% HOXB4-transduced cells and 70% nontransduced(C) The rapid HSC expansion was confirmed in four independent
cells. Yet the HSC expansion was confined to theexperiments, with HOXB4 cultures (white bars) undergoing an aver-
age 6-fold HSC expansion by day 6, in contrast to an average 17- HOXB4-GFP cell population, suggesting that the 40-
fold reduction seen for GFP cultures (dark bars). fold net expansion reported here might even be an un-
derestimate of the true level of expansion achieved by
HOXB4-transduced HSCs.
overall level of reconstitution was roughly equivalent for The quality of the expanded HSCs was not impaired,
the two groups (Figure 3A), the level of HSC regeneration as demonstrated by their ability to fully repopulate all
was much higher in the HOXB4 mice. We determined lineages. Significantly, all mice transplanted with HOXB4-
that each GFP-transduced HSC expanded approxi- expanded HSCs remained healthy and without any man-
mately 70-fold in vivo (95% confidence intervals [CI]: ifestations of hematopoietic disorder (e.g., myeloprolif-
10–500 CRU), while each HOXB4-transduced HSC ex- erative disease) for extended observation periods (9
panded approximately 5000-fold (95% CI: 1,400–22,400 months). Moreover, we confirmed that expanded HSCs
CRU) (Figure 4B). Thus, HOXB4-transduced HSCs, which retained significant proliferative potential. We previously
previously expanded 40-fold ex vivo (as a population), demonstrated enhanced HSC regenerative ability in
were still capable of massive in vivo expansion, regener- HOXB4-transduced bone marrow cells (Antonchuk et
ating the HSC compartment to near-normal size. Fur- al., 2001; Sauvageau et al., 1995; Thorsteinsdottir et
thermore, the in vivo expanded HOXB4 HSCs still pro- al., 1999). We now examined the regenerative ability in
vided significant reconstitution of the lymphoid and HOXB4-transduced cells following 40-fold ex vivo HSC
myeloid lineages (not shown). expansion. We show here that the hyperregenerative
potential of HOXB4 is retained after ex vivo expansion,
and thus the extensive ex vivo HSC growth did not impairPolyclonal Expansion of HOXB4-Transduced HSCs
To resolve whether the documented HOXB4 growth ad- the ability of HOXB4 cells to expand extensively in vivo.
In fact, by this measurement, the HOXB4-expandedvantage occurred on a large number of HSCs versus on
a restricted subset of such cells, we sought to estimate HSCs are qualitatively better than unmanipulated HSCs.
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Figure 3. Lympho-Myeloid Repopulation by
Ex Vivo Expanded Stem Cells
(A) Representative FACS profiles demonstra-
ting multilineage repopulation by transduced
cells. GFP-expressing cells were present in
(from left) myeloid (Gr-1 or Mac-1) and ery-
throid (Ter119) bone marrow cells, B-lym-
phoid (B220) splenocytes, and T-lymphoid
(CD5) thymocytes of mice transplanted 9
months previously at limit dilution from 6- to
10-day GFP or HOXB4 cultures. HOXB4 (bot-
tom row) and GFP (top row) mice show equiv-
alent multilineage repopulation, consistent
with unimpaired differentiative ability.
(B) Representative Southern blots (eight mice
per group analyzed, with similar results) dem-
onstrate common proviral insertion sites in
reconstituted myeloid and lymphoid tissues.
Common proviral bands are present in en-
riched or purified myeloid, T-lymphoid, and
B-lymphoid populations from each mouse,
indicating that a common repopulating cell
clone repopulated all lineages. Abbrevia-
tions: B, bone marrow cells; S, splenocytes;
T, thymocytes; BG,M, Gr-1 or Mac-1 bone
marrow cells; SB220, B220 splenocytes; and
T4,8, CD4 or CD8 thymocytes.
HOXB4 overexpression may also increase cell prolif- giving further promise to potential therapeutic applica-
tions of HOXB4 overexpression.eration. It has been argued that the morphological
changes seen in Hox mutants may be due to modifica- Recent findings indicate that HOXB4 may also re-
program mouse embryonic stem cells into long-termtion of local growth rates (Duboule, 1995). Studies in
RAT-1 cells showed that HOXB4 overexpression acti- repopulating cells, opening new avenues to therapeutic
cloning of HSCs (Kyba et al., 2001). These results rein-vated the expression of AP-1 complex genes Fra-1 and
Jun-B, with subsequent upregulation of cyclin D1 (Krosl force our current study, which demonstrates that ex
vivo HSC expansion is achievable under conditions thatand Sauvageau, 2000). We previously demonstrated that
HOXB4 overexpression enhanced ex vivo growth of total include high expression levels of HOXB4. In addition,
the rapid ex vivo HSC expansion induced by HOXB4bone marrow cultures and that this effect was due to
increased proliferation rather than reduced apoptosis shown here, combined with new avenues of engineering
direct protein delivery to cells (e.g., HIV TAT tags; Naga-(Antonchuk et al., 2001). We now show that the HOXB4-
mediated growth advantage is largely restricted to the hara et al., 1998), suggest that it should be possible to
develop a HOXB4 protein that can act as a HSC-specificmost primitive hematopoietic cell populations: in 14
days there was a 2-fold enhancement to total (mostly mitogen. Such findings open new exciting avenues for
cellular and genetic manipulation of HSCs.mature) cell growth, a 3-fold enhancement to progenitor
cell growth, and a 1000-fold enhancement to HSC
Experimental Proceduresgrowth. The primitive cell-specific growth advantage
suggests enhanced HSC proliferation and/or an en-
Retroviral Vectors
hanced probability of self-renewal mediated by HOXB4 Generation of the MSCV-IRES-GFP and MSCV-HOXB4-IRES-GFP
overexpression. vectors and the GPE86-based producer cells were described pre-
viously (Antonchuk et al., 2001). Retroviral titres of the GFP andThe potential use of HOXB4 or a downstream effector
HOXB4 producer cells were 3 105 /ml and 2 105 /ml, respectively,in human therapeutic applications including HSC trans-
as assessed by transfer of GFP expression to NIH-3T3 cells.plantation is buoyed by recent findings in the human
system. Overexpression of HOXC4 in human bone mar-
Mice
row cells led to ex vivo expansion of clonogenic progeni- Parental strain mouse breeders were originally purchased from The
tors and long-term culture-initiating cells (LTC-IC; Daga Jackson Laboratory (Bar Harbor, ME) and subsequently bred and
maintained at the British Columbia Cancer Research Centre animalet al., 2000). HOXC4 is a paralog of HOXB4, and the
facility according to the guidelines of the Canadian Council on Ani-similar overexpression phenotype suggests an overlap-
mal Care. They were housed in microisolator units and providedping function between members of the 4th paralog group
with sterilized food, water, and bedding. Irradiated animals werein promoting a primitive state. Ongoing studies indicate
additionally provided with acidified water (pH 3.0). Bone marrow
that overexpression of HOXB4 also allows the expansion transplant donors were C57Bl6/Ly-Pep3b (Pep3b) and express
of human HSCs as detected by their capacity to repopu- Ly5.1, and recipients were C57Bl/6-W41/W41 (W41) and express
Ly5.2.late immuno-compromised mice (R.K.H., submitted),
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Figure 4. Regeneration of HSCs Following Ex Vivo Expansion
(A) Representative FACS profiles of bone marrow from mice trans-
planted with (from left) 1 GFP HSC, 1 HOXB4 HSC, or 37 HOXB4
HSCs from the 14-day cultures reveals them all to be highly repopu-
lated by transduced (GFP), donor-derived (Ly5.1) cells.
Ly5.1GFP cells represent transduced cell progeny in the erythroid
lineage, which do not express Ly5.1.
(B) Calculated HSC (CRU) content in pooled bone marrow from
the above groups of mice (n  2 GFP or 3 HOXB4 primary mice)
demonstrated that only the HOXB4 mice had regenerated HSCs to
near the normal range (dotted line).
Infection of Primary Murine Bone Marrow Cells
Primary mouse bone marrow cells were transduced as previously
described (Antonchuk et al., 2001). Briefly, bone marrow cells were Figure 5. Clonality of Expanded HSCs
extracted from mice treated 4 days previously with 150 mg/kg
The degree of clonality in repopulating cells recovered from the5-fluorouracil (Faulding, Vaudreuil, PQ, Canada) and cultured for 48
cultures was determined by Southern blot analysis of bone marrowhr in DMEM supplemented with 15% fetal bovine serum (FBS), 10
from mice transplanted with HOXB4 or GFP cells from 10- to 14-ng/ml hIL-6, 6 ng/ml mIL-3, and 100 ng/ml mSF. Media and serum
day cultures. The first number denotes the experiment number (i.e.,were purchased from StemCell Technologies (Vancouver, BC, Can-
1 or 2), and the second number denotes the individual mice. GFPada), and growth factors were expressed from cloned cDNAs in
mice 1.1–1.4 received 0.5 transduced HSC (2.5  106 cells) on dayCOS cells and purified in the Terry Fox Laboratory. After stimulation,
10, and GFP mice 2.1–2.4 received 10 transduced HSCs (2  107the cells were harvested and infected by either cocultivation with
cells) on day 10. HOXB4 mice 1.1–1.5 received 15 transduced HSCsirradiated (1500 cGy X-ray) GPE86 viral producer cells or by the
(2.5  105 cells) on day 10, HOXB4 mice 1.6–1.8 received 37 trans-addition of virus-containing supernatant from the GPE86 producer
duced HSCs (1.3  106 cells) on day 14, and HOXB4 mice 2.1–2.4cells. Both infection protocols involved 48 hr growth on tissue cul-
received 47 transduced HSCs (6  103 cells) on day 10. GFP miceture plates with the above cytokine combinations and with the addi-
from each of two experiments have common banding patterns, indi-tion of 5 g/ml protamine sulfate (Sigma, Oakville, ON, Canada).
cating that few HSC clones survived. However, HOXB4 mice haveLoosely adherent and nonadherent cells were recovered from the
differing banding patterns, revealing the persistence of multiplecocultures, and all cells were recovered from the supernatant infec-
transduced repopulating cell clones after the ex vivo expansion.tions. Following the infection procedure, bone marrow cells were
cultured a further 6–10 days in the same medium, without protamine
sulfate. On days 0, 2, and 4 during the infection and days 6, 10, and
labeled B220 or a combination of PE-labeled Gr-1 and PE-labeled14 following the infection, cells were counted on a hematocytometer,
Mac-1 (all antibodies from Pharmingen, Mississauga, ON, Canada).and an aliquot was removed for FACS, CFC, and CRU assays. All
All samples were washed with HF and 1 g/ml PI prior to analysisof the remaining cells from days 0 or 2, and 107 cells from each
on FACScalibur.culture on days 4, 6, and 10, were replated at 2  105 cells/ml.
CFC AssayFlow Cytometry
Hematopoietic clonogenic progenitor frequencies were determinedApproximately 105 cells from each liquid culture sample were
by plating suitable aliquots of bone marrow or spleen cells in methyl-washed once with Hank’s balanced salt solution (StemCell Technol-
cellulose medium (HCC-3334, StemCell Technologies) containing 3ogies) with 2% FBS (HF), and then once with HF and 1 g/ml propid-
U/ml erythropoietin and supplemented with 50 ng/ml mSF, 10 ng/ium iodide (PI; Sigma) prior to analysis of GFP expression on a
ml hIL-6, and 10 ng/ml mIL-3 and then by scoring the resultantFACScalibur (Becton Dickinson, Mississauga, ON, Canada). For
colonies after 10 days of incubation.analysis of transplant recipients, 100 l of blood was extracted
from the tail vein, and the erythrocytes were lysed with ammonium
chloride (StemCell Technologies). Leukocyte samples suspended CRU Assay
HSCs were detected and evaluated using a limiting dilution trans-in HF were incubated sequentially on ice with biotinylated anti-Ly5.1,
then with APC-labeled streptavidin and either phycoerythrin (PE)- plantation-based assay for cells with competitive, long-term,
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